Precigen, Inc. (PGEN)
3.83
-0.06
(-1.54%)
USD |
NASDAQ |
Mar 27, 11:54
Precigen Total Liabilities (Quarterly) : 135.71M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.274M |
| Amneal Pharmaceuticals, Inc. | 3.672B |
| Corcept Therapeutics, Inc. | 190.22M |
| CorMedix, Inc. | 472.32M |
| Viridian Therapeutics, Inc. | 177.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 156.62M |
| Shareholders Equity (Quarterly) | 20.91M |
| Debt to Equity Ratio | 4.700 |
| Current Ratio | 3.089 |
| Net Debt Paydown Yield | -1.25% |